Schedule 13D ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2018-11-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
39,852,842
Percent of class
27.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-063144
Form type
SC 13D/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Dec 04, 2018
Reporting period
Nov 27, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub